Lataa...

MALAT1 accelerates the development and progression of renal cell carcinoma by decreasing the expression of miR‐203 and promoting the expression of BIRC5

OBJECTIVE: We aimed to investigate the roles of the lncRNA MALAT1 in renal cell carcinoma (RCC) progression. METHODS: qRT‐PCR was used for the assessment of BIRC5, miRNA‐203 and MALAT1 expression. Furthermore, the targeted relationships between miR‐203 and BIRC5, as well as MALAT1 and miR‐203, were...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cell Prolif
Päätekijät: Zhang, Haimin, Li, Wei, Gu, Wenyu, Yan, Yang, Yao, Xudong, Zheng, Junhua
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2019
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6797509/
https://ncbi.nlm.nih.gov/pubmed/31250518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12640
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!